RNU6-1247P

Across TCGA pan-cancer cohorts, RNU6-1247P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-1247P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-1247P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1247P expression acts as an unfavorable survival marker.

ACC, KIRC, and SKCM are the cancer types where RNU6-1247P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.116	0.638	<.001	72	view →
KIRC	OS	Tertile	All	0.442	0.669	.001	67	view →
SKCM	OS	Tertile	All	0.616	0.883	<.001	48	view →
PAAD	DFS	Tertile	All	0.262	0.500	.001	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
UCS	DFS	Tertile	III,IV	0.153	0.439	.049	18	view →
THCA	OS	Tertile	IV	0.581	0.878	.030	15	view →
BRCA	DFS	Tertile	II,III,IV	0.221	0.525	.012	12	view →
BLCA	DFS	Tertile	IV	0.125	0.489	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-1247P–ACC (OS)

Open the ACC breakdown →